Principles and Practice of Clinical Bacteriology Second Edition - Free

38 ORAL AND OTHER NON-β-HAEMOLYTIC STREPTOCOCCI
Kawamura, Y., Hou, X.G., Sultana, F. et al. (1995a) Determination of 16S
rRNA sequences of Streptococcus mitis and Streptococcus gordonii and
phylogenetic relationships among members of the genus Streptococcus.
International Journal of Systematic Bacteriology, 45, 406–408.
Kawamura, Y., Hou, X.G., Sultana, F. et al. (1995b) Transfer of Streptococcus
adjacens and Streptococcus defectivus to Abiotrophia gen. nov. as
Abiotrophia adiacens comb. nov. and Abiotrophia defectiva comb.
nov., respectively. International Journal of Systematic Bacteriology,
45, 798–803.
Kawamura, Y., Hou, X.G., Todome, Y. et al. (1998) Streptococcus peroris sp.
nov. and Streptococcus infantis sp. nov., new members of the Streptococcus
mitis group, isolated from human clinical specimens. International Journal
of Systematic Bacteriology, 48, 921–927.
Kelly, C.G., Younson, J.S., Hikmat, B.Y. et al. (1999) A synthetic peptide
adhesion epitope as a novel antimicrobial agent. Nature Biotechnology, 17,
42–47.
Kennedy, H.F. and Smith, A.J. (2000) Viridans streptococcal infection in the
medically compromised. Reviews in Medical Microbiology, 11, 77–86.
Kikuchi, K., Enari, T., Totsuka, K. and Shimizu, K. (1995) Comparison of
phenotypic characteristics, DNA–DNA hybridization results, and results
with a commercial rapid biochemical and enzymatic reaction system for
identification of viridans group streptococci. Journal of Clinical Microbiology,
33, 1215–1222.
Kilian, M. (2001) Recommended conservation of the names Streptococcus
sanguis, Streptococcus rattus, Streptococcus cricetus, and seven other
names included in the Approved Lists of Bacterial Names. Request for an
opinion. International Journal of Systematic and Evolutionary Microbiology,
51, 723–724.
Kilian, M., Mikkelsen, L. and Henrichsen, J. (1989) Taxonomic study of
viridans streptococci: description of Streptococcus gordonii sp. nov. and
emended descriptions of Streptococcus sanguis (White and Niven 1946),
Streptococcus oralis (Bridge and Sneath 1982), and Streptococcus mitis
(Andrewes and Horder, 1906). International Journal of Systematic
Bacteriology, 39, 471–484.
Kiliç, A.O., Herzberg, M.C., Meyer, M.W. et al. (1999) Streptococcal reporter
gene-fusion vector for identification of in vivo expressed genes. Plasmid,
42, 67–72.
Kitada, K., Nagata, K., Yakushiji, T. et al. (1992) Serological and biological
characteristics of “Streptococcus milleri” isolates from systemic purulent
infections. Journal of Medical Microbiology, 36, 143–148.
Kitada, K., Inoue, M. and Kitano, M. (1997) Experimental endocarditis
induction and platelet aggregation by Streptococcus anginosus, Streptococcus
constellatus and Streptococcus intermedius. FEMS Immunology and
Medical Microbiology, 19, 25–32.
Kitten, T., Munro, C.L., Wang, A. and Macrina, F.L. (2002) Vaccination with
FimA from Streptococcus parasanguis protects rats from endocarditis caused
by other viridans streptococci. Infection and Immunity, 70, 422–425.
Koga, T., Oho, T., Shimazaki, Y. and Nakano, Y. (2002) Immunization against
dental caries. Vaccine, 20, 2027–2044.
Kolenbrander, P.E., Andersen, R.N., Baker, R.A. and Jenkinson, H.F. (1998)
The adhesion-associated sca operon in Streptococcus gordonii encodes an
inducible high-affinity ABC transporter for Mn 2 + uptake. Journal of
Bacteriology, 180, 290–295.
Kugler, K.C., Denys, G.A., Wilson, M.L. and Jones, R.N. (2000) Serious
streptococcal infections produced by isolates resistant to streptogramins
(quinupristin/dalfopristin): case reports from the SENTRY antimicrobial
surveillance program. Diagnostic Microbiology and Infectious Disease, 36,
269–272.
Kuramitsu, H.K. (2003) Molecular genetic analysis of the virulence of oral
bacterial pathogens: an historical perspective. Critical Reviews in Oral
Biology and Medicine, 14, 331–344.
Lee, R.A., Woo, P.C., To, A.P. et al. (2003) Geographical difference of disease
association in Streptococcus bovis bacteraemia. Journal of Medical Microbiology,
52, 903–908.
Lefort, A., Lortholary, O., Casassus, P. et al. (2002) Comparison between adult
endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and
G) and Streptococcus milleri: a multicenter study in France. Archives of
Internal Medicine, 162, 2450–2456.
Lisby, G., Gutschik, E. and Durack, D.T. (2002) Molecular methods for
diagnosis of infective endocarditis. Infectious Disease Clinics of North
America, 16, 393–412.
Lockhart, P.B. and Durack, D.T. (1999) Oral microflora as a cause of endocarditis
and other distant site infections. Infectious Disease Clinics of North
America, 13, 833–850.
Lowrance, J.H., Baddour, L.M. and Simpson, W.A. (1990) The role of
fibronectin binding in the rat model of experimental endocarditis caused by
Streptococcus sanguis. The Journal of Clinical Investigation, 86, 7–13.
Macey, M.G., Whiley, R.A., Miller, L. and Nagamune, H. (2001) Effect on
polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin,
expressed by Streptococcus intermedius. Infection and Immunity,
69, 6102–6109.
Marron, A., Carratala, J., Alcaide, F. et al. (2001) High rates of resistance to
cephalosporins among viridans-group streptococci causing bacteraemia in
neutropenic cancer patients. The Journal of Antimicrobial Chemotherapy,
47, 87–91.
Marsh, P.D. (2003) Are dental diseases examples of ecological catastrophes
Microbiology, 149, 279–294.
McNab, R., Holmes, A.R., Clarke, J.M. et al. (1996) Cell surface polypeptide
CshA mediates binding of Streptococcus gordonii to other oral
bacteria and to immobilized fibronectin. Infection and Immunity, 64,
4204–4210.
McWhinney, P.H., Patel, S., Whiley, R.A. et al. (1993) Activities of potential
therapeutic and prophylactic antibiotics against blood culture isolates of
viridans group streptococci from neutropenic patients receiving
ciprofloxacin. Antimicrobial Agents and Chemotherapy, 37, 2493–2495.
Morris, A.M. and Webb, G.D. (2001) Antibiotics before dental procedures for
endocarditis prophylaxis: back to the future. Heart, 86, 3–4.
Mouly, S., Ruimy, R., Launay, O. et al. (2002) The changing clinical aspects
of infective endocarditis: descriptive review of 90 episodes in a French
teaching hospital and risk factors for death. The Journal of Infection, 45,
246–256.
Mouton, J.W., Endtz, H.P., den Hollander, J.G. et al. (1997) In-vitro activity of
quinupristin/dalfopristin compared with other widely used antibiotics
against strains isolated from patients with endocarditis. The Journal of
Antimicrobial Chemotherapy, 39(Suppl. A), 75–80.
Munro, C.L. and Macrina, F.L. (1993) Sucrose-derived exopolysaccharides of
Streptococcus mutans V403 contribute to infectivity in endocarditis.
Molecular Microbiology, 8, 133–142.
Mylonakis, E. and Calderwood, S.B. (2001) Infective endocarditis in adults.
The New England Journal of Medicine, 345, 1318–1330.
Nagamune, H., Ohnishi, C., Katsuura, A. et al. (1996) Intermedilysin, a novel
cytotoxin specific for human cells secreted by Streptococcus intermedius
UNS46 isolated from a human liver abscess. Infection and Immunity, 64,
3093–3100.
Nagamune, H., Whiley, R.A., Goto, T. et al. (2000) Distribution of the intermedilysin
gene among the anginosus group streptococci and correlation
between intermedilysin production and deep-seated infection with
Streptococcus intermedius. Journal of Clinical Microbiology, 38, 220–226.
Nagashima, H., Takao, A. and Maeda, N. (1999) Abscess forming ability of
Streptococcus milleri group: synergistic effect with Fusobacterium nucleatum.
Microbiology and Immunology, 43, 207–216.
NINSS (2003) Surveillance of Hospital-Acquired Bacteraemia in English
Hospitals, 1997–2002. PHLS, London. www.hpa.org.uk/infections/
publications/ninns/hosacq_HAB_2002.pdf (10 February 2004).
Petersen, F.C., Pasco, S., Ogier, J. et al. (2001) Expression and functional
properties of the Streptococcus intermedius surface protein antigen I/II.
Infection and Immunity, 69, 4647–4653.
Petersen, F.C., Assev, S., van der Mei, H.C. et al. (2002) Functional variation
of the antigen I/II surface protein in Streptococcus mutans and Streptococcus
intermedius. Infection and Immunity, 70, 249–256.
Pfaller, M.A., Jones, R.N., Marshall, S.A. et al. (1997) Nosocomial streptococcal
blood stream infections in the SCOPE Program: species occurrence and
antimicrobial resistance. The SCOPE Hospital Study Group. Diagnostic
Microbiology and Infectious Disease, 29, 259–263.
PHLS (2001) Non-pyogenic and group B streptococcal bacteraemias, England
and Wales: 1999 and 2000. CDR Weekly, 11(42). www.hpa.org.uk/cdr/
PDFfiles/2001/cdr4201.pdf (10 February 2004).
PHLS (2002) Pyogenic and non-pyogenic streptococcal bacteraemias, England
and Wales: 2001. CDR Weekly, 12(16). www.hpa.org.uk/cdr/PDFfiles/
2002/cdr1602.pdf (10 February 2004).
Poyart, C., Pierre, C., Quesne, G. et al. (1997) Emergence of vancomycin
resistance in the genus Streptococcus: characterization of a vanB transferable
determinant in Streptococcus bovis. Antimicrobial Agents and Chemotherapy,
41, 24–29.
Poyart, C., Quesne, G. and Trieu-Cuot, P. (1998) Taxonomic dissection of the
Streptococcus bovis group by analysis of manganese-dependent superoxide
dismutase gene (sodA) sequences: reclassification of ‘Streptococcus
infantarius subsp. coli’ as Streptococcus lutetiensis sp. nov. and of